Alnylam Pharmaceuticals CEO Yvonne Greenstreet discusses why RNAI can be used to treat an array of diseases, the company's medicines using this technology, and more.
 Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a>

Alnylam Pharmaceuticals CEO Yvonne Greenstreet discusses why RNAI can be used to treat an array of diseases, the company's medicines using this technology, and more. Learn more about your ad choices. Visit megaphone.fm/adchoices

Alnylam Pharmaceuticals CEO Yvonne Greenstreet discusses why RNAI can be used to treat an array of diseases, the company's medicines using this technology, and more.
 Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices" rel="noopener noreferrer">megaphone.fm/adchoices</a>

Biotech CEO on RNAI and Medicine of the Future

Join Barron’s Andy Serwer as he sits down with top CEOs and business leaders to discuss the biggest stories in business, including the economy, emerging technologies such as artificial intelligence, leadership, corporate culture, and more. Every week, our guests offer unique insight into their companies and the broader corporate world to help you see around corners and understand what's next. At Barron’s also unpacks the human side of top executives, including the challenges and experiences that made them into the leaders they are today.

Share Biotech CEO on RNAI and Medicine of the Future

Sign up to save your podcasts

Biotech CEO on RNAI and Medicine of the Future

Biotech CEO on RNAI and Medicine of the Future

More shows like At Barron's

WSJ Tech News Briefing

WSJ Your Money Briefing

Investing Insights

Notes on the Week Ahead

Masters in Business

Goldman Sachs Exchanges

WSJ Minute Briefing

Bold Names

Wall Street Breakfast

Numbers by Barron's

The Readback

Thoughts on the Market

Barron's Streetwise

Barron's Advisor

Barron's Live

Goldman Sachs The Markets

WSJ's Take On the Week